Bionano Genomics, Inc. — Director's Dealing 2022

Feb 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc. (BNGO)
CIK: 0001411690
Period of Report: 2022-02-15

Reporting Person: OLDAKOWSKI MARK (Chief Operating Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-15	Stock Option (Right to Buy)	$2.18	A	650000	Acquired	2032-02-14	Common Stock (650000)	Direct

Footnotes

F1: The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.